Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Muscle Nerve. 2018 Nov 26;59(2):201–207. doi: 10.1002/mus.26335

Table 4.

Test for treatment effect from LME model

Tests – difference in slope between groups Change 95% CI p-value
Rasagiline v Placebo 0.26 (−0.19,+0.71) 0.26
Rasagilne v Historical Controls 0.12 (−0.14,+0.38) 0.36
Placebo v Historical Controls −0.14 (−0.55,+0.27) 0.50
Rasagiline v (Placebo + Historical Controls)
Unadjusted 0.13 (−0.12,+0.39) 0.30
Adjusted for Symptom Duration 0.09 (−0.16,+0.34) 0.16
Adjusted for Riluzole Use and Symptom Duration 0.10 (−0.15,+0.35) 0.43

V = versus; CI = confidence interval